Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Rare Cancers Europe: New name and new action

At the occasion of the 2011 European Multidisciplinary Cancer Congress held from 23-27 September 2011 in Stockholm, Sweden, the European Action Against Rare Cancers initiative presented its new name and logo, Rare Cancers Europe, as well as its new tagline: Joining forces for action.
24 Sep 2011

Short and easy to remember, the new name, Rare Cancers Europe, replaces an old and rather long name that was often mistaken for the European Partnership for Action Against Cancer. By using colours rarely seen in health care, the new logo of Rare Cancers Europe embodies the concept of rarity. Its crossword (puzzle) shape alludes to the specific challenges associated with rare cancers and visualises the fact that international cooperation across stakeholder groups is paramount in order to effectively address those challenges.

The new tagline, Joining forces for action, reflects the initiative’s commitment to partnership and action by reinforcing that the challenges posed by rare cancers can only be effectively addressed if all stakeholder groups involved work together to develop and implement consensus-based, viable solutions.

To do this, the Rare Cancers Europe multi-stakeholder partnership has identified three main fields of action, namely the methodology of clinical research on rare cancers, the need for centres of expertise and European reference networks as well as clinical practice guidelines, and timely and equal access to rare cancer treatment and care across the European Union.

A series of corresponding activities will be developed and implemented over the course of the coming months, starting with a first-ever Rare Cancers Conference that looks at ways to improve the methodology of clinical research on rare cancers. The meeting will be held on 10 February 2012 in Brussels, Belgium, and will include an overview of rare cancers and related research challenges as well as the outcome of a consensus discussion process with all stakeholders that has just been kicked off.

Last update: 24 Sep 2011

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings